Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Vavra

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 1, 1991
[The value of adjuvant irradiation in patients with cervical carcinoma in histopathological stage Ib and negative lymph nodes]N Vavra, H Kucera, U Denison, et al.
Gynakologische Rundschau|January 1, 1991
[Supportive measures for cytostatic therapy of gynecologic cancers]P Sevelda, N Vavra, M Barrada, et al.
Zeitschrift Fur Geburtshilfe Und Perinatologie|July 1, 1991
[Cervix carcinoma in pregnancy]N Vavra, M Barrada, A Rosen, et al.
British Journal of Obstetrics and Gynaecology|August 1, 1990
Oestrogen and progesterone receptor content as a prognostic factor in advanced epithelial ovarian carcinomaP Sevelda, U Denison, M Schemper, et al.
British Journal of Cancer|September 1, 1993
Primary carcinoma of the fallopian tube--a retrospective analysis of 115 patients. Austrian Cooperative Study Group for Fallopian Tube CarcinomaA Rosen, M Klein, M Lahousen, et al.
Wiener Klinische Wochenschrift|August 3, 1990
[The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma]P Sevelda, M Barrada, N Vavra, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1993
[High-dose epirubicin in combination with high-dose ifosfamide plus granulocyte colony stimulating factor in patients with advanced platin-pretreated ovarian cancer. Phase I-II study]E Küffer, B Fazeny, P Speiser, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 1992
Goserelin a GnRH-analogue as third-line therapy of refractory epithelial ovarian cancerP. Sevelda, N. Vavra, R. Fitz, et al.
Geburtshilfe Und Frauenheilkunde|March 1, 1992
[Prognostic factors of radically operated stage Ib cervix cancer]N Vavra, H Kucera, W Eppel, et al.
Gynecologic Oncology|June 1, 1997
Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter studyCh Kurz, Ch Marth, G Windbichler, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 1, 1991
[The value of adjuvant irradiation in patients with cervical carcinoma in histopathological stage Ib and negative lymph nodes]N Vavra, H Kucera, U Denison, et al.
Gynakologische Rundschau|January 1, 1991
[Supportive measures for cytostatic therapy of gynecologic cancers]P Sevelda, N Vavra, M Barrada, et al.
Zeitschrift Fur Geburtshilfe Und Perinatologie|July 1, 1991
[Cervix carcinoma in pregnancy]N Vavra, M Barrada, A Rosen, et al.
British Journal of Obstetrics and Gynaecology|August 1, 1990
Oestrogen and progesterone receptor content as a prognostic factor in advanced epithelial ovarian carcinomaP Sevelda, U Denison, M Schemper, et al.
British Journal of Cancer|September 1, 1993
Primary carcinoma of the fallopian tube--a retrospective analysis of 115 patients. Austrian Cooperative Study Group for Fallopian Tube CarcinomaA Rosen, M Klein, M Lahousen, et al.
Wiener Klinische Wochenschrift|August 3, 1990
[The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma]P Sevelda, M Barrada, N Vavra, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1993
[High-dose epirubicin in combination with high-dose ifosfamide plus granulocyte colony stimulating factor in patients with advanced platin-pretreated ovarian cancer. Phase I-II study]E Küffer, B Fazeny, P Speiser, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 1992
Goserelin a GnRH-analogue as third-line therapy of refractory epithelial ovarian cancerP. Sevelda, N. Vavra, R. Fitz, et al.
Geburtshilfe Und Frauenheilkunde|March 1, 1992
[Prognostic factors of radically operated stage Ib cervix cancer]N Vavra, H Kucera, W Eppel, et al.
Gynecologic Oncology|June 1, 1997
Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter studyCh Kurz, Ch Marth, G Windbichler, et al.
Pageof 10